VT – Vyripharm Technologies

VT – Vyripharm Technologies

Global Leader in Agribiopharmaceuticals Data

In a rapidly changing market, VT is redefining the global technology landscape. We leverage our blockchain technology and artificial intelligence platform to synthesize information that advances personalized, precision medicine.

API and Cloud-based Biomedical Informatics Infrastructure based on Block-Chain Architecture

Vyripharm Technologies, the Company’s IT/Big Data and IoT Platform has patent-pending a blockchain architecture called the Biotechnology Informatics Infrastructure (“BI²™”), to compliment the testing platform which will be developed as an integrated medicinal supply chain technological tracking system/verification including forward/backward product traceability, chain of custody and patient tracking of outcomes. Vyripharm Technologies (VT) is building the data collection, repository and analytics infrastructure called Biopharmaceutical Informatics Infrastructure (BI²™).

Bridging the Big Data /
IOT Gap with BI²™

BI²™️ bridges the gap between cultivators, processors, R&D, Global Pharma/Biotechnology and the medical community. This blockchain data repository contains an immutable ledger. Stakeholders at each step in the supply chain provide data that is collected, measured, tested, certified, verified, traced, and tracked.

Our proprietary technologies disrupt and accelerate the traditional development and discovery process allowing us to shorten the average timeline from inception to commercialization.

Drag View


Helping People Live Better Lives

Quality Assurance and Quality Control is Vyripharm’s focus for enhancing public safety, public health and public awareness.